Profile data is unavailable for this security.
About the company
Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. It has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. It has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.
- Revenue in USD (TTM)98.99k
- Net income in USD-2.17m
- Incorporated2007
- Employees3.00
- LocationTherapeutic Solutions International Inc701 Wild Rose LaneELK CITY 83525United StatesUSA
- Phone+1 (760) 295-7208
- Websitehttps://therapeuticsolutionsint.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dynatronics Corp | 35.18m | -5.70m | 2.26m | 154.00 | -- | 0.2783 | -- | 0.0644 | -1.38 | -1.38 | 8.39 | 3.43 | 1.09 | 3.16 | 7.84 | 228,421.30 | -15.46 | -6.02 | -21.69 | -8.30 | 21.52 | 27.33 | -14.12 | -4.55 | 0.6695 | -19.74 | 0.1955 | -- | -8.41 | -8.81 | -19.84 | -- | -5.11 | -- |
| Invo Bioscience Inc | 3.02m | -8.03m | 2.36m | 25.00 | -- | -- | -- | 0.781 | -9.13 | -9.13 | 2.57 | 0.3582 | 0.2417 | 6.73 | 27.75 | 120,822.80 | -64.30 | -94.63 | -120.25 | -151.45 | 41.20 | 74.91 | -266.00 | -343.11 | 0.1211 | -6.86 | 0.7558 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 2.47m | 9.00 | -- | -- | -- | 1.53 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| VirExit Technologies Inc | 0.00 | -1.80m | 2.56m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
| Nuwellis Inc | 8.86m | -22.63m | 2.60m | 59.00 | -- | 0.325 | -- | 0.2936 | -13.45 | -13.45 | 4.51 | 0.5651 | 0.5147 | 1.67 | 5.28 | 150,237.30 | -117.35 | -98.07 | -152.04 | -122.48 | 56.22 | 55.22 | -227.99 | -230.51 | 1.96 | -5.06 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Vycor Medical Inc | 1.46m | -387.45k | 2.74m | 8.00 | -- | -- | -- | 1.88 | -0.0122 | -0.0124 | 0.0432 | -0.1019 | 1.58 | 0.6002 | 7.86 | 182,575.00 | -6.81 | -47.86 | -- | -- | 90.08 | 89.60 | -4.32 | -35.42 | 0.0859 | 0.389 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| Tenon Medical Inc | 2.93m | -15.58m | 3.13m | 21.00 | -- | 2.81 | -- | 1.07 | -10.28 | -10.28 | 1.62 | 0.2992 | 0.3359 | 3.48 | 7.85 | 139,428.60 | -178.74 | -- | -264.89 | -- | 42.38 | -- | -532.14 | -- | 1.06 | -- | 0.6012 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 3.18m | 233.00 | -- | -- | -- | 0.4439 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Therapeutic Solutions International Inc | 98.99k | -2.17m | 3.38m | 3.00 | -- | 2.70 | -- | 34.19 | -0.0007 | -0.0007 | 0.00003 | 0.0003 | 0.0287 | 1.13 | 4.44 | 32,996.67 | -64.51 | -162.32 | -169.11 | -- | 62.85 | 67.79 | -2,247.41 | -2,391.85 | 0.0333 | -4.92 | 0.373 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 3.43m | 15.00 | -- | 0.4469 | -- | 5.98 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| Sharps Technology Inc | 0.00 | -9.84m | 3.86m | 3.00 | -- | 0.4744 | -- | -- | -0.7645 | -0.7645 | 0.00 | 0.5195 | 0.00 | -- | -- | -- | -83.30 | -- | -109.78 | -- | -- | -- | -- | -- | 0.8474 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Innovative Eyewear Inc | 1.15m | -6.66m | 3.88m | 11.00 | -- | 0.5159 | -- | 3.37 | -0.6442 | -0.6442 | 0.1098 | 0.4303 | 0.2113 | 4.05 | 11.33 | 104,770.90 | -122.17 | -- | -137.62 | -- | -10.35 | -- | -578.18 | -- | 8.14 | -2,255.11 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.68m | -11.39m | 3.92m | 31.00 | -- | 0.589 | -- | 0.4522 | -3.77 | -3.77 | 1.46 | 0.2841 | 0.796 | 0.8515 | 4.52 | 279,935.50 | -104.44 | -136.06 | -215.93 | -194.32 | 63.93 | 56.30 | -131.22 | -408.36 | 1.74 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Catheter Precision Inc | 442.00k | -71.37m | 4.17m | 14.00 | -- | 0.1827 | -- | 9.44 | -25.32 | -25.32 | 0.0806 | 3.02 | 0.0186 | 1.36 | 6.45 | 31,571.43 | -296.70 | -- | -376.14 | -- | 93.21 | -- | -15,966.52 | -- | 1.67 | -- | 0.0086 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Venus Concept Inc | 76.35m | -37.25m | 4.24m | 304.00 | -- | -- | -- | 0.0555 | -6.86 | -6.86 | 14.05 | -2.54 | 0.6972 | 1.03 | 2.30 | 251,164.50 | -33.83 | -32.71 | -50.39 | -44.01 | 68.32 | 68.16 | -48.52 | -48.50 | 1.39 | -3.93 | 1.22 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 4.35m | 15.00 | -- | -- | -- | 1.91 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
Data as of May 07 2024. Currency figures normalised to Therapeutic Solutions International Inc's reporting currency: US Dollar USD
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Strategic Investment Solutions, Inc. (Illinois)as of 31 Dec 2023 | 3.00k | 0.00% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
